MRCP2-2271
A 35-year-old male presents with a rash and low-grade fever (37.6°C) three weeks after receiving an allogeneic bone marrow transplant for high-risk acute myeloid leukemia in first complete remission. Initially, the rash is maculopapular and affects his palms and soles. However, after 24 hours, general erythroderma is noted on his trunk and limbs. Although his total bilirubin was previously normal, it is now 40 µmol/L (1-22). Despite these symptoms, he remains in good health. What would be the appropriate management for this patient at this stage?